An ASTM committee tasked with addressing issues related to process control, design and performance as well as quality acceptance/assurance tests for the pharmaceutical manufacturing industry will meet to discuss current and future standards for pharmaceutical and biopharmaceutical manufacturing.

In partnership with the Food and Drug Administration (FDA), ASTM International Committee E55 on Manufacture of Pharmaceutical and Biopharmaceutical Products is sponsoring the workshop on October 11 at the FDA’s facility in Silver Springs, Md. While the workshop focuses on current and future standards activities within pharmaceutical and biopharmaceutical manufacturing, it will take place in conjunction with the committee’s standards development meetings.

 According to ASTM International, the workshop is designed to share Committee E55’s mission, accomplishments and future plans as well as to understand the FDA expectations about quality and operational standards. The workshop will also include interaction sections with participation of industry leaders and FDA representatives on four topics: continuous manufacturing, viral filtration, data management and single-use systems.

 Online registration closes September 30. For more information, visit